The Other Side

https://www.sciencedaily.com/releases/2026/01/260130041105.htm

Researchers have found a way to make ordinary aluminum tubes float indefinitely, even when submerged for long periods or punched full of holes. By engineering the metal’s surface to repel water, the tubes trap air inside and refuse to sink, even in rough conditions. The technology could eventually be scaled up into floating platforms, ships, or even wave-powered energy systems.

https://www.sciencedaily.com/releases/2026/01/260130041105.htm

https://www.sciencedaily.com/releases/2026/01/260129080428.htm

A fast-aging fish is giving scientists a rare, accelerated look at how kidneys grow old—and how a common drug may slow that process down. Researchers found that SGLT2 inhibitors, widely used to treat diabetes and heart disease, preserved kidney structure, blood vessels, and energy production as the fish aged, while also calming inflammation. The results help explain why these drugs protect kidneys and hearts so reliably in people, even beyond blood sugar control.

https://www.sciencedaily.com/releases/2026/01/260129080428.htm

https://www.sciencedaily.com/releases/2026/01/260128075345.htm

Two decades after a breast cancer vaccine trial, every participant is still alive—an astonishing result for metastatic disease. Scientists found their immune systems retained long-lasting memory cells primed to recognize cancer. By enhancing a key immune signal called CD27, researchers dramatically improved tumor elimination in lab studies. The findings suggest cancer vaccines may have been missing a crucial ingredient all along.

https://www.sciencedaily.com/releases/2026/01/260128075345.htm

https://www.sciencedaily.com/releases/2026/01/260128075336.htm

Order doesn’t always form perfectly—and those imperfections can be surprisingly powerful. In materials like liquid crystals, tiny “defects” emerge when symmetry breaks, shaping everything from cosmic structures to everyday technologies. Now, researchers have developed an AI-powered method that can predict how these defects will form and evolve in milliseconds instead of hours. By learning directly from data, the system accurately maps molecular alignments and complex defect behavior, even in situations where defects merge or split.

https://www.sciencedaily.com/releases/2026/01/260128075336.htm

https://www.sciencedaily.com/releases/2026/01/260129080440.htm

An experimental drug once known for helping control type 2 diabetes may also fight heart disease. Researchers found IC7Fc lowered cholesterol, blood fats, and artery-clogging plaques while calming inflammation linked to heart attacks and strokes. Notably, these benefits appeared even without weight loss, suggesting the drug could help lean people at risk of heart disease.

https://www.sciencedaily.com/releases/2026/01/260129080440.htm